Different Ultrafiltration Rates and Intradialytic Hypotension.

Association of Ultrafiltration Rates and Intradialytic Hypotension in Sohag University Hospitals.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06695923

Enrollment

Registered

2024-11-19

Start date

2025-02-01

Completion date

2026-01-01

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis, Intradialytic Hypotension

Keywords

Ultrafiltration rates, Intradialytic hypotension

Brief summary

Finding relationship between different ultrafiltration rates and intradialytic hypotension in attempt to find the optimal cut off points.

Detailed description

This observational study will be carried upon hemodialysis patients with different ultrafiltration rates at each session to study the association between ultrafiltration rates and intradialytic hypotension. Thus identifying the optimal cut off of ultrafiltration rate points for each patient

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All patients aged 18 Year or older on maintenance haemodialysis for at least 3 consecutive months receiving 3 sessions weekly. \-

Exclusion criteria

Patients aged \< 18 years old. Patients on recent haemodialysis \< 3 months. Pregnant women. Patients with malignancy, severe infections or sepsis. Patients with major bleeding. Patients who cannot go upper limb monitoring of blood pressure. Patients with severe heart failure (NYHA) class 3 or more. Patients with severe anemia, Hemoglobin less than 6 g/dl.

Design outcomes

Primary

Measure	Time frame	Description
Prevent Intradialytic Hypotension	6 month	Finding the optimal threshold of ultrafiltration rates to prevent intradialytic hypotension through observing the risk factors associated with the occurrence of HDH
Clinical History Among the Study Patients.	6 months	Analysis of the prevalence of chronic illness among the study participants, as well as the number of antihypertensive drugs used.

Countries

Egypt

Baseline characteristics

Characteristic	—
Age, Continuous	48.59 years STANDARD_DEVIATION 14.61
Region of Enrollment Egypt	50 Participants
Sex: Female, Male Female	27 Participants
Sex: Female, Male Male	23 Participants

Adverse events

Event type	EG000 affected / at risk
deaths Total, all-cause mortality	2 / 50
other Total, other adverse events	0 / 50
serious Total, serious adverse events	0 / 50

Outcome results